PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 5 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
DGL root extracts showed strong antimicrobial activity in the planktonic phase and significantly inhibited biofilm formation at concentrations over 4 µg/ml (glucose) or 16 µg/ml (sucrose) [PMID:23123832].
DGL was used as part of a naturopathic intervention to provide symptomatic relief of acid reflux in a patient with Parkinson's disease [PMID:31043910].
A randomized double-blind placebo-controlled trial evaluated fermented DGL (FDGL) containing α-amylase for the treatment of early-stage diabetic polyneuropathy [PMID:41627541].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30000900 (2006) — Evaluating the protective role of Deglycyrrhizinated licorice root supplement on bleomycin induced pulmonary oxidative damage. · Toxicology mechanisms and methods
- 2.PMID: 23123832 (2012) — The antimicrobial effects of deglycyrrhizinated licorice root extract on Streptococcus mutans UA159 in both planktonic and biofilm cultures. · Anaerobe
- 3.PMID: 41627541 (2026) — Randomized Double-blind Placebo-controlled study to evaluate the efficacy of fermented deglycyrrhizinated licorice for treatment of diabetic polyneuropathy. · Endocrine
- 4.PMID: 34422484 (2021) — How Much Is Too Much? Exploring Pseudohyperaldosteronism in Glycyrrhizic Acid Toxicity From Chronic Licorice Root Consumption. · Cureus
- 5.PMID: 31043910